Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

References for PMC Articles for PubMed (Select 18648322)

1.

Synaptic plasticity (and the lack thereof) in hippocampal CA2 neurons.

Zhao M, Choi YS, Obrietan K, Dudek SM.

J Neurosci. 2007 Oct 31;27(44):12025-32.

2.

Long-term enzyme replacement therapy for pompe disease with recombinant human alpha-glucosidase derived from chinese hamster ovary cells.

Rossi M, Parenti G, Della Casa R, Romano A, Mansi G, Agovino T, Rosapepe F, Vosa C, Del Giudice E, Andria G.

J Child Neurol. 2007 May;22(5):565-73.

PMID:
17690063
3.

Astrocyte glycogen and brain energy metabolism.

Brown AM, Ransom BR.

Glia. 2007 Sep;55(12):1263-71. Review.

PMID:
17659525
4.

Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited.

Schoser BG, Müller-Höcker J, Horvath R, Gempel K, Pongratz D, Lochmüller H, Müller-Felber W.

Neuropathol Appl Neurobiol. 2007 Oct;33(5):544-59. Epub 2007 Jun 15.

PMID:
17573812
5.

Optimized preservation of CNS morphology for the identification of glycogen in the Pompe mouse model.

Taksir TV, Griffiths D, Johnson J, Ryan S, Shihabuddin LS, Thurberg BL.

J Histochem Cytochem. 2007 Oct;55(10):991-8. Epub 2007 May 17.

PMID:
17510371
6.
7.

Fatigue: an important feature of late-onset Pompe disease.

Hagemans ML, van Schie SP, Janssens AC, van Doorn PA, Reuser AJ, van der Ploeg AT.

J Neurol. 2007 Jul;254(7):941-5. Epub 2007 Mar 2.

8.

Acid alpha-glucosidase deficiency (Pompe disease).

Fukuda T, Roberts A, Plotz PH, Raben N.

Curr Neurol Neurosci Rep. 2007 Jan;7(1):71-7. Review.

PMID:
17217857
9.

Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease.

Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, Leslie N, Levine J, Spencer C, McDonald M, Li J, Dumontier J, Halberthal M, Chien YH, Hopkin R, Vijayaraghavan S, Gruskin D, Bartholomew D, van der Ploeg A, Clancy JP, Parini R, Morin G, Beck M, De la Gastine GS, Jokic M, Thurberg B, Richards S, Bali D, Davison M, Worden MA, Chen YT, Wraith JE.

Neurology. 2007 Jan 9;68(2):99-109. Epub 2006 Dec 6. Erratum in: Neurology. 2008 Nov 18;71(21):1748.

PMID:
17151339
10.

Increased aortic stiffness in glycogenosis type 2 (Pompe's disease).

Nemes A, Soliman OI, Geleijnse ML, Anwar AM, van der Beek NA, van Doorn PA, Gavallér H, Csajbók E, ten Cate FJ.

Int J Cardiol. 2007 Aug 9;120(1):138-41. Epub 2006 Nov 3.

PMID:
17084921
11.

Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease.

Thurberg BL, Lynch Maloney C, Vaccaro C, Afonso K, Tsai AC, Bossen E, Kishnani PS, O'Callaghan M.

Lab Invest. 2006 Dec;86(12):1208-20. Epub 2006 Oct 30.

12.

Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.

van der Beek NA, Hagemans ML, van der Ploeg AT, Reuser AJ, van Doorn PA.

Acta Neurol Belg. 2006 Jun;106(2):82-6. Review.

PMID:
16898258
13.

A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease.

Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D; Infantile-Onset Pompe Disease Natural History Study Group.

J Pediatr. 2006 May;148(5):671-676.

PMID:
16737883
14.

Lysosomal dysfunction, cellular pathology and clinical symptoms: basic principles.

Reuser AJ, Drost MR.

Acta Paediatr Suppl. 2006 Apr;95(451):77-82. Review.

PMID:
16720471
15.

Ambulatory electrocardiogram analysis in infants treated with recombinant human acid alpha-glucosidase enzyme replacement therapy for Pompe disease.

Cook AL, Kishnani PS, Carboni MP, Kanter RJ, Chen YT, Ansong AK, Kravitz RM, Rice H, Li JS.

Genet Med. 2006 May;8(5):313-7.

PMID:
16702882
16.

Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease.

Fukuda T, Ewan L, Bauer M, Mattaliano RJ, Zaal K, Ralston E, Plotz PH, Raben N.

Ann Neurol. 2006 Apr;59(4):700-8.

PMID:
16532490
17.

Course of disability and respiratory function in untreated late-onset Pompe disease.

Hagemans ML, Hop WJ, Van Doorn PA, Reuser AJ, Van der Ploeg AT.

Neurology. 2006 Feb 28;66(4):581-3.

PMID:
16505317
18.

Enzyme replacement for lysosomal diseases.

Brady RO.

Annu Rev Med. 2006;57:283-96. Review.

PMID:
16409150
19.

Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease.

Pellegrini N, Laforet P, Orlikowski D, Pellegrini M, Caillaud C, Eymard B, Raphael JC, Lofaso F.

Eur Respir J. 2005 Dec;26(6):1024-31.

20.

The natural course of non-classic Pompe's disease; a review of 225 published cases.

Winkel LP, Hagemans ML, van Doorn PA, Loonen MC, Hop WJ, Reuser AJ, van der Ploeg AT.

J Neurol. 2005 Aug;252(8):875-84. Review.

PMID:
16133732
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk